Hancock R E
Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada.
Clin Infect Dis. 1998 Aug;27 Suppl 1:S93-9. doi: 10.1086/514909.
Nonfermentative gram-negative bacilli are still a major concern in compromised individuals. By far the most important of these organisms is Pseudomonas aeruginosa, although Acinetobacter baumannii (previously Acinetobacter calcoaceticus), Stenotrophomonas maltophilia (previously Pseudomonas and Xanthomonas maltophilia), and Burkholderia cepacia (previously Pseudomonas cepacia) are also of substantative concern because of their similar high intrinsic resistances to antibiotics. The basis for the high intrinsic resistance of these organisms is the lower outer-membrane permeability of these species, coupled with secondary resistance mechanisms such as an inducible cephalosporinase or antibiotic efflux pumps, which take advantage of low outer-membrane permeability. Even a small change in antibiotic susceptibility of these organisms can result in an increase in the MIC of a drug to a level that is greater than the clinically achievable level. In this review, the major mechanisms of resistance observed in the laboratory and clinic are summarized.
非发酵革兰氏阴性杆菌仍是免疫功能低下者的主要关注点。到目前为止,这些微生物中最重要的是铜绿假单胞菌,尽管鲍曼不动杆菌(以前称为醋酸钙不动杆菌)、嗜麦芽窄食单胞菌(以前称为嗜麦芽假单胞菌和嗜麦芽黄单胞菌)以及洋葱伯克霍尔德菌(以前称为洋葱假单胞菌)也因其对抗生素具有相似的高固有耐药性而备受关注。这些微生物高固有耐药性的基础是这些菌种较低的外膜通透性,再加上诸如诱导型头孢菌素酶或抗生素外排泵等二级耐药机制,这些机制利用了低外膜通透性。这些微生物对抗生素敏感性的哪怕是微小变化都可能导致药物的最低抑菌浓度升高到超过临床可达到水平。在本综述中,总结了在实验室和临床中观察到的主要耐药机制。